The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
about
Assessing harmful effects in systematic reviewsThe Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of EvidenceSystematic review of the effectiveness of stage based interventions to promote smoking cessation.General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy.Cost-effectiveness of extended cessation treatment for older smokersCardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study.Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol.Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic reviewAn economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trialNicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial.The use of bupropion SR in cigarette smoking cessationPromoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers.Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.Financial incentives for smoking cessation in low-income smokers: study protocol for a randomized controlled trial.A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessationInternet-based photoaging within Australian pharmacies to promote smoking cessation: randomized controlled trial.A comprehensive model for mental health tobacco recovery in new jersey.Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparisonCosts and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.A review of economic evaluations of tobacco control programs.Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trialPromoting smoking cessation in Bangladeshi and Pakistani male adults: design of a pilot cluster randomised controlled trial of trained community smoking cessation workers.Nicotine competes with a visual stimulus for control of conditioned respondingCost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.Governments, pay for smoking cessation.Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial.
P2860
Q24795698-54915F9F-0D3F-438F-97F1-07ED24A4A4E3Q26799108-7BE28DC3-4985-49C7-BB9A-68D61F5A1B4FQ30477963-A0AA3738-0DF7-46D6-8D20-4ED4F8837F84Q33263051-310FE999-A9E0-4D92-A7A1-64D724A3AB5BQ33268086-C68348E1-20C1-4FDD-84CE-0F60C532C0F1Q33610016-F73810F2-4813-4459-83CB-61474F47B27DQ33627663-FB47DEB0-A306-4FE0-90FC-84B8E403CF98Q34034226-B577149F-2BA0-437F-8FE8-BDF1C32C49EFQ34049603-79545343-57DB-4713-9EAF-9CBC7C01F60BQ34245935-B80BEED3-4097-47E6-8178-E11634CAC1AAQ34332212-53B09A71-5A96-4DF9-8765-261617DC6EBBQ34470058-A00F9458-F529-4974-B4F4-33703978CDEAQ34779470-E7FF16E5-7AFF-4C34-B699-85FD107C55BBQ35225609-6A816985-849D-4199-868C-9F5C38871C44Q35523164-B6C9E1F5-B3CD-47D0-9DD6-EAF480C34291Q35538980-78CFADEE-6BFF-4CC6-B370-11B6ED21CB82Q35964545-F350B0E7-8CDC-4CE4-B297-FDD9D927E47CQ36478377-B06458C6-2B70-48B4-A99D-5E47313EC5BEQ36481665-B8492585-3945-4AE8-A580-C384E5D914AFQ36795002-5F0FC422-E86C-498C-976B-1EB0035507B4Q36800503-4494EEB5-B063-4993-8C3E-E6A04ED054F5Q36930315-D3A3E757-2CA7-4A20-927D-9D98CF54E140Q37005883-66794AC6-F779-4B07-9FF0-DA5A4D3BD019Q37115779-9797CCBB-20A0-4DFD-869E-CFEC50A17E83Q37167092-36392700-619C-4A3D-BD55-008859B0FD6DQ37184340-93A9177B-D69D-43C6-91AE-F69A96F13CF5Q37353297-1C72F07A-B8AA-4BF4-B14F-9CB24F9D1A97Q41052113-15AD9CB8-27F0-48B4-B7BB-5D3635C89CF2Q41676984-126103F8-41ED-47CF-B1B9-0EAC4DC14D25Q42540153-DC019DFE-06C9-4C02-9236-BC7CAE417E0EQ47309365-B0D2A9DD-4759-4C40-A7D6-2A6578CE879BQ48512290-51BCCDA1-42D5-44EE-88E2-5CECF662A9D4
P2860
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
type
label
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
prefLabel
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
P2093
P1476
The clinical effectiveness and ...... eview and economic evaluation.
@en
P2093
Aveyard PN
Raftery JP
Woolacott NF
P577
2002-01-01T00:00:00Z